Alternative Data for Orasure Technologies
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 5 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 9,000 | Sign up | Sign up | Sign up |
| Employee Rating | 60 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 9 | Sign up | Sign up | Sign up |
| Facebook Followers | 779 | Sign up | Sign up | Sign up |
| Instagram Followers | 294 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 2,177 | Sign up | Sign up | Sign up |
| X Followers | 706 | Sign up | Sign up | Sign up |
| X Mentions | 5 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 28 | Sign up | Sign up | Sign up |
| Linkedin Employees | 436 | Sign up | Sign up | Sign up |
About Orasure Technologies
OraSure Technologies, Inc., together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally.
| Price | $2.73 |
| Target Price | Sign up |
| Volume | 435,940 |
| Market Cap | $195M |
| Year Range | $2.11 - $3.48 |
| Dividend Yield | 0% |
| PE Ratio | 27.82 |
| Analyst Rating | 0% buy |
| Industry | Medical & Dental Instruments |
In the news
$450 Billion Drug Delivery Devices Market Industry Forecast, 2035January 27 - GlobeNewswire |
|
OraSure Technologies Confirms Receipt of Director Nominations from Altai CapitalJanuary 15 - GlobeNewswire |
|
OraSure Submits CT/NG Molecular Self-Test and Colli-Pee™ Urine Collection Device for FDA ReviewJanuary 5 - GlobeNewswire |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 27M | 15M | 12M | -14M | -13M | -0.130 |
| Q2 '25 | 31M | 18M | 13M | -20M | -15M | -0.190 |
| Q1 '25 | 30M | 18M | 12M | -16M | -15M | -0.180 |
| Q4 '24 | 37M | 24M | 14M | -11M | -9.9M | -0.060 |
| Q3 '24 | 40M | 23M | 17M | -4.5M | -3.4M | -0.060 |
Insider Transactions View All
| Gagliano Nancy J filed to buy 160,254 shares at $2.4. December 2 '25 |
| EGLINTON MANNER CARRIE filed to buy 1,288,334 shares at $3.5. March 3 '25 |
| Marmora Lelio filed to buy 67,720 shares at $3.1. February 27 '25 |
| McGrath Kenneth J filed to buy 371,013 shares at $3.2. February 27 '25 |
| Kenny John P. filed to buy 70,915 shares at $3.2. February 27 '25 |
Similar companies
Read more about Orasure Technologies (OSUR) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - Orasure Technologies
The Market Cap of Orasure Technologies is $195M.
As of today, Orasure Technologies' PE (Price to Earnings) ratio is 27.82.
Currently, the price of one share of Orasure Technologies stock is $2.73.
The OSUR stock price chart above provides a comprehensive visual representation of Orasure Technologies' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Orasure Technologies shares. Our platform offers an up-to-date OSUR stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Orasure Technologies (OSUR) does not offer dividends to its shareholders. Investors interested in Orasure Technologies should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Orasure Technologies are Align Technology, Dentsply, LeMaitre Vascular, iRhythm Technologies, and NovoCure.
